INSM
Price
$143.34
Change
-$2.03 (-1.40%)
Updated
Sep 24, 12:08 PM (EDT)
Capitalization
30.73B
29 days until earnings call
NWPHF
Price
$9.36
Change
-$2.64 (-22.00%)
Updated
Sep 9 closing price
Capitalization
257.68M
Interact to see
Advertisement

INSM vs NWPHF

Header iconINSM vs NWPHF Comparison
Open Charts INSM vs NWPHFBanner chart's image
Insmed
Price$143.34
Change-$2.03 (-1.40%)
Volume$200
Capitalization30.73B
Newron Pharmaceuticals SPA
Price$9.36
Change-$2.64 (-22.00%)
Volume$500
Capitalization257.68M
INSM vs NWPHF Comparison Chart in %
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. NWPHF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Hold and NWPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (INSM: $145.38 vs. NWPHF: $9.36)
Brand notoriety: INSM and NWPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 64% vs. NWPHF: 100%
Market capitalization -- INSM: $30.73B vs. NWPHF: $257.68M
INSM [@Biotechnology] is valued at $30.73B. NWPHF’s [@Biotechnology] market capitalization is $257.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileNWPHF’s FA Score has 1 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • NWPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than NWPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 2 TA indicator(s) are bullish.

  • INSM’s TA Score: 2 bullish, 6 bearish.

Price Growth

INSM (@Biotechnology) experienced а +0.44% price change this week, while NWPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.31%. For the same industry, the average monthly price growth was +10.10%, and the average quarterly price growth was +53.89%.

Reported Earning Dates

INSM is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+4.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($30.7B) has a higher market cap than NWPHF($258M). INSM YTD gains are higher at: 110.574 vs. NWPHF (0.000).
INSMNWPHFINSM / NWPHF
Capitalization30.7B258M11,899%
EBITDA-938.1MN/A-
Gain YTD110.5740.000-
P/E RatioN/AN/A-
Revenue398MN/A-
Total Cash1.86BN/A-
Total Debt576MN/A-
FUNDAMENTALS RATINGS
INSM vs NWPHF: Fundamental Ratings
INSM
NWPHF
OUTLOOK RATING
1..100
7742
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
514
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3871
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NWPHF's Valuation (62) in the null industry is in the same range as INSM (77) in the Biotechnology industry. This means that NWPHF’s stock grew similarly to INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (5) in the Biotechnology industry is in the same range as NWPHF (14) in the null industry. This means that INSM’s stock grew similarly to NWPHF’s over the last 12 months.

INSM's SMR Rating (99) in the Biotechnology industry is in the same range as NWPHF (100) in the null industry. This means that INSM’s stock grew similarly to NWPHF’s over the last 12 months.

INSM's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for NWPHF (71) in the null industry. This means that INSM’s stock grew somewhat faster than NWPHF’s over the last 12 months.

INSM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NWPHF (100) in the null industry. This means that INSM’s stock grew similarly to NWPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSMNWPHF
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
10%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
8%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
75%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IJJ129.960.16
+0.12%
iShares S&P Mid-Cap 400 Value ETF
IWMY23.39-0.01
-0.04%
Defiance R2000 Target 30 Income ETF
ESUM27.17-0.13
-0.47%
Eventide Us Market ETF
NKX12.52-0.08
-0.63%
Nuveen California AMT-Free Quality Municipal Income Fund
NERD28.03-0.26
-0.92%
Roundhill Video Games ETF

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.24%
THAR - INSM
76%
Closely correlated
-3.09%
NWPHF - INSM
49%
Loosely correlated
N/A
CARM - INSM
46%
Loosely correlated
-3.47%
NUVL - INSM
45%
Loosely correlated
+2.76%
ROIV - INSM
42%
Loosely correlated
-1.34%
More

NWPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NWPHF has been loosely correlated with INSM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NWPHF jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWPHF
1D Price
Change %
NWPHF100%
N/A
INSM - NWPHF
49%
Loosely correlated
+0.24%
SGMT - NWPHF
35%
Loosely correlated
-1.17%
MMIRF - NWPHF
30%
Poorly correlated
N/A
NURPF - NWPHF
5%
Poorly correlated
N/A
PRVCF - NWPHF
4%
Poorly correlated
-26.00%
More